Quarterly report · Q1
2385.TEDINET S100S775
Period2023-07-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2023-07-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥501m | 2023-07-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥496m | 2023-07-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥497m | 2023-07-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥46m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥527m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥452m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥528m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥16m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥7.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥8.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥902m | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥-20.15 | 2023-07-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.27 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.53 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 85.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue external | 2023-07-01 → 2023-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥78m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥57m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥57m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥11m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥166m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥166m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥148m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥677m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥676m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥645,000 |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥267m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥71m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥67m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | segment profit | 2023-07-01 → 2023-09-30 | −¥8m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥157m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥157m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥11m |
| —segment total | revenue | 2023-07-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue external | 2023-07-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥4m |
| —segment total | segment profit | 2023-07-01 → 2023-09-30 | −¥423m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2022-09-30 | ¥600,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥77m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥89m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥89m |
| jpcrp040300-q1r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | −¥13m |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥282m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥732m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥732m |
| jpcrp040300-q1r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2022-09-30 | −¥184m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥138m |
| jpcrp040300-q1r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥23m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥148m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥148m |
| jpcrp040300-q1r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥15m |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥2.2bn |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥2.2bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥123m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 310
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-07-01 | |
| Current period end date | FilingDateInstant | 2023-09-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2024-06-30 | |
| Previous fiscal year start date | FilingDateInstant | 2022-07-01 | |
| Comparative period end date | FilingDateInstant | 2022-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-06-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所（グロース市場） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |